Literature DB >> 3438149

Influence of haemodialysis on the pharmacokinetics of ciprofloxacin.

J P Samsom1.   

Abstract

The elimination of ciprofloxacin from serum was studied in 16 patients (10 F, 6M, age 44-70 years) with end stage renal disease, treated with haemodialysis. The dosage of ciprofloxacin was 200 mg i.v. given by bolus injection (10 patients) or 250 mg orally (6 patients) on a day without and a day with dialysis (8 hours before dialysis was started). Samples were taken at regular intervals from the arteriovenous shunt and from venous peripheral blood. Concentrations of ciprofloxacin were measured by a biological assay. The mean peak serum levels after 200 mg i.v. were 3.5 mg/l measured 0.5 hour after the gift. After an oral dose of 250 mg the mean peak serum level measured one hour after the gift amounted to 1.5 mg/l. The serum half life was 8.5 h without dialysis and 5.5 h with dialysis. It was calculated from AUC values during dialysis that about 15% of the drug was eliminated by the artificial kidney.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3438149     DOI: 10.1007/BF02075254

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  1 in total

1.  The pharmacokinetics of ciprofloxacin in patients with impaired renal function.

Authors:  J Boelaert; Y Valcke; M Schurgers; R Daneels; M Rosseneu; M T Rosseel; M G Bogaert
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

  1 in total
  2 in total

Review 1.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 2.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.